Solara Active Pharma Sciences Profit & Loss Annual

Trade
BSE: 541540 | NSE: SOLARA | ISIN: INE624Z01016 | Sector: Biotechnology & Drugs
786.60 -11.80 (-1.48%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,288.921,443.811,268.341,616.88
Total Revenue 1,288.921,443.811,268.341,616.88
Costof Revenue Total 805.02894.71746.01808.48
Gross Profit 483.90549.10522.33808.40
Selling/ General/ Admin Expenses Total 243.92401.23429.61408.62
Depreciation/ Amortization 103.33110.54111.64107.98
Unusual Expense( Income) 190.17-3.49-
Other Operating Expenses Total 335.169.096.396.52
Total Operating Expense 1,677.601,416.221,297.821,332.28
Operating Income -388.6827.59-29.48284.60
Interest Inc( Exp) Net- Non- Op Total -1,051.10-782.50-626.10-639.00
Other Net 5.376.291.76-1.20
Net Income Before Taxes -488.42-44.82-91.10221.50
Provisionfor Income Taxes 78.54-22.57-32.810.15
Net Income After Taxes -566.96-22.25-58.29221.35
Minority Interest -0.430.070.140.05
Net Income Before Extra Items -567.39-22.18-58.15221.40
Net Income -567.39-22.18-58.15221.40
Income Availableto Com Excl Extra Ord -567.39-22.18-58.15221.40
Income Availableto Com Incl Extra Ord -567.39-22.18-58.15221.40
Diluted Net Income -567.39-22.18-58.15221.40
Diluted Weighted Average Shares 3.913.603.593.43
Diluted EPS Excluding Extra Ord Items -145.25-6.16-16.1864.53
Diluted Normalized EPS -113.60-6.08-15.4163.94
Interest Exp( Inc) Net- Operating Total -6.506.806.80
Gain( Loss)on Saleof Assets --4.50-7.7020.00
DPS- Common Stock Primary Issue ---7.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts